Home Healthcare Biotechnology Spectrometry Market

Spectrometry Market Size, Share & Trends Analysis Report By Type (Molecular Spectrometry, Mass Spectrometry, Atomic Spectrometry), By Product (Instrument, Consumables, Services), By Application (Pharmaceutical Analysis, Forensic Analysis, Proteomics, Metabolomics, Others), By End-Use (Government and Academic Institutions, Pharmaceutical and Biotechnology Companies, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Dhanashri Chandgude | Format:

Spectrometry Market Size

The global spectrometry market size was valued at USD 20.63 billion in 2025 and is projected to grow from USD 22.14 billion in 2026 to USD 38.96 billion by 2034, registering a CAGR of 7.32% during the forecast period from 2026 to 2034. North America dominated the spectrometry market with a market share of 38.4% in 2025.

Spectrometry is a process that is used to examine and measure a certain spectrum and is often used in samples. Atomic spectrometry, mass spectrometry, and molecular spectrometry are all examples of spectrometry. Atomic spectroscopy is said to be the investigation of how atoms absorb and emit electromagnetic radiation. When using mass spectrometry, the mass-to-charge ratio is used to determine the mass of the chemical sample. Molecular spectrometry is a term used to describe the process of measuring the interactions between electromagnetic radiation and matter.

It is possible to employ spectrometry to determine the molecular or structural composition of a sample in physical as well as analytical chemistry. Each atom or molecule in the sample is examined, and its spectra are measured in this process. Electromagnetic radiation's contact with materials creates an electromagnetic spectrum that may be studied and analyzed in terms of wavelength or frequency. By ionizing and isolating a test sample, it is possible to detect specific substances, like chemical compounds, contaminants, pollutants, or impurities. Various molecular, mass, and atomic spectroscopy techniques can be used to investigate a sample, depending on its nature and requirements.

Spectrometry Market Size

Download a Free Sample To learn more about this report.

Type Insights

The Global Market is segmented into Molecular Spectrometry, Mass Spectrometry, and Atomic Spectrometry. Molecular spectrometry held more than 40% of the market's revenue share in 2021, owing to its widespread use in life science sectors and the commercial accessibility of advanced and innovative goods in this segment. PerkinElmer, Inc.,

  • for example, provides a wide range of equipment, accessories, consumables, as well as software and informatics for molecular spectroscopy, among other things. One of the reasons for its escalating success in the market is that infrared-based molecular spectroscopy systems have become more efficient and cost-effective in the biotechnology, pharmaceutical, as well as forensic industries.

The mass spectrometry (or MS) market is expected to expand at a healthy rate over the next few years. In forensics, biotechnology, pharmacology, and clinical research, MS is a potent tool for the investigation of a wide spectrum of compounds. Mass spectrometry has made it possible to offer high-resolution test findings in a timely manner.

Spectrometry Market Size By Segments

Request Customizationto receive a tailored report.

Product Insights

The Global Market is segmented into Instrument, Consumables, and Services. Nearly 75% of market share in the year 2021 was generated by instruments. In biotechnology, spectrometry has taken a substantial chunk of the market share. MS has helped researchers identify 27 biomarkers that can be used to forecast the severity of an individual's sickness and create appropriate treatment. The proteomics of adoptive cell treatments in cancer treatment, such as CAR-T, are also analyzed using MS, which is also employed in MS. Forecasts indicate that this will account for a significant portion of the segment's sales over this time period.

Businesses that provide spectrometry services are projected to benefit from an increase in demand for their products and services. It is expected that private sector competition will continue to drive the expansion of the services sector over this period.

Application Insights

The Global Market is segmented into Pharmaceutical Analysis, Forensic Analysis, Proteomics, Metabolomics, and Others. For pharmaceutical analysis category, which accounted for over 40% of the market's revenue in 2021, the CAGR is predicted to be fastest. As part of the pharmaceutical analysis, a number of procedures are used to determine a drug's composition or identify its components in solution or mixtures, as well as to purify and quantify the substance.

Devices for pharmaceutical analysis are available from a number of key vendors. Pharmaceutical companies are using spectrometer technology to measure medications in unique ways. It was found that using LC-MS technique, anti-COVID-19 medicine remdesivir's effectiveness in treating disease could be accurately quantified in human blood samples.

End-Use Insights

The Global Market is segmented into Government & Academic Institutions, Pharmaceutical & Biotechnology Companies, and Others. As of 2021, roughly 45% of the market's income was generated by the government & academic institutions segment. There are a variety of government and academic institutions using spectrometry techniques and related items in their study. Because of this, the marketplace for spectrometry goods is likely to grow.

The expansion of the market is projected to be boosted by the existence of academic institutions and institutes. From 2022 to 2030, the end-use segment of pharmaceutical and biotechnology industries is predicted to increase at the quickest rate. The pharmaceutical & biotechnology industry's usage of spectrometry techniques, particularly mass spectrometry, is driving the segment's expansion. As a result, the demand for medication component analysis as well as biomolecule analysis is propelling the segment.

Spectrometry Market Share By Segments

Speak to an Analystto discuss market opportunities.

Regional Insights

The spectrometry market was dominantly acquired by the North American region, which is expected to hold a revenue share of about 50% in 2021. Because of the large number of prominent firms, like Agilent Technologies, Thermo Fisher Scientific, and Waters Corporation, in the area, this can be credited. There is a strong research basis for new medication development in the Asia-Pacific region, which is projected to drive the market's quickest growth.

In 2021, North America held a commanding lead in the market and was responsible for the greatest revenue share, which was close to 50%. This can be due to the presence of a substantial number of prominent firms locally, like Thermo Fisher Scientific, Waters Corporation, Agilent Technologies, and others. In addition, the presence of a number of organizations and groups that are active in this sector and that take measures to generate and promote awareness about the new innovative spectrometry technologies and products is another positive aspect of this area.

Additionally, a surge in research and development activities being conducted by significant players for innovative diseases can be attributed to the area that makes up the majority of the world's market. Players in the industry like Agilent Technologies, Inc. are continually active in intensive research & development to produce new resins for the separation and purification of vaccines. At the moment, the organization is concentrating its efforts on the development of a COVID-19 vaccine and the separation of its components through the use of chromatography as well as mass spectrometry techniques. The characterization of potential vaccines is accomplished by the use of the MS method.

North America Spectrometry Market Revenue Share 2025

Unlock Regional Insightsto access country-level data, & regional trends.

Asia-Pacific Spectrometry Market Trends

Because there is a robust research basis for the creation of novel drugs in the Asia-Pacific region, it is anticipated that this market will have the highest rate of growth of any market worldwide. It is anticipated that this will increase the number of instances of this technique being utilized in the region. As a result of a growth in the proportion of spectrometry service providers, Asian countries such as China and Japan, together with India, have made substantial contributions to the expansion of the industry.

List of Key and Emerging Players in Spectrometry Market

Thermo Fisher Scientific, Inc.
PerkinElmer, Inc.
Bruker Corporation
JEOL Ltd.
Agilent Technologies
Endress+Hauser Group
MKS Instruments, Inc.
Waters Corporation
Shimadzu Corporation
FLIR Systems, Inc.

Key Industry Developments

June 2026
Thermo Fisher Scientific launched a next-generation high-resolution mass spectrometry platform with enhanced sensitivity and faster analytical performance for pharmaceutical, environmental, and life sciences research. The system improves sample throughput and data accuracy.
April 2026
Agilent Technologies expanded its spectroscopy and mass spectrometry portfolio with new AI-enabled analytical software that streamlines data interpretation and laboratory workflows. The enhancement supports faster and more reliable analytical testing.
February 2026
Bruker introduced advanced MALDI and FT-MS spectrometry solutions designed for proteomics, metabolomics, and clinical research applications. The new systems provide higher resolution and improved analytical precision.
October 2025
Shimadzu Corporation launched an upgraded LC-MS system featuring improved ionization efficiency and automated operation for pharmaceutical quality control and academic research laboratories.

Report Scope

Segmentation

By Type 3
  • Molecular Spectrometry
  • Mass Spectrometry
  • Atomic Spectrometry
By Product 3
  • Instrument
  • Consumables
  • Services
By Application 5
  • Pharmaceutical Analysis
  • Forensic Analysis
  • Proteomics
  • Metabolomics
  • Others
By End-Use 3
  • Government and Academic Institutions
  • Pharmaceutical and Biotechnology Companies
  • Others

Geographies Covered

North America 2
  • U.S.
  • Canada
Europe 8
  • U.K.
  • Germany
  • France
  • Spain
  • Italy
  • Russia
  • Nordic
  • Benelux
APAC 7
  • China
  • Korea
  • Japan
  • India
  • Australia
  • Taiwan
  • Southeast Asia
Middle East and Africa 6
  • UAE
  • Turkey
  • Saudi Arabia
  • South Africa
  • Egypt
  • Nigeria
LATAM 5
  • Brazil
  • Mexico
  • Argentina
  • Chile
  • Colombia
Competitive Coverage Thermo Fisher Scientific, Inc. · PerkinElmer, Inc. · Bruker Corporation · JEOL Ltd. · Agilent Technologies
Research Deliverables Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Customize This Report to Match Your Strategic Objectives

Frequently Asked Questions (FAQs)

The spectrometry market size is valued at USD 22.14 Billion in 2026 and is projected to reach USD 38.96 Billion by 2034, at a CAGR of 7.32% during the forecast period 2026-2034.
North America dominated the market with a share of 38.4% in 2025.
The leading players in this market are Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Bruker Corporation.
The spectrometry market is projected to grow at a CAGR of 7.32% during the forecast period of 2026 2034.
About the Author
Dhanashri Chandgude
Dhanashri Chandgude
Senior Research Associate

Dhanashri Chandgude is a healthcare research professional with over four years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.

Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.

Report Details
−
Trusted by Industry Leaders
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Request Sample Order Report Now